Isolated Thoracic Perfusion (ITP-F) for MPM
NCT02467426 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23
Last updated 2015-06-10
Summary
This is an observational study of isolated thoracic perfusion with subsequent hemofiltration to lower the concentration of the cytotoxic drugs as a locoregional therapeutic strategy in malignant pleural mesothelioma.
Conditions
Interventions
- DRUG
-
intraarterial infusion of cisplatin and mithoxantrone
Sponsors & Collaborators
-
Medias Klinikum for Surgical Oncology
lead OTHER
Principal Investigators
-
Karl R. Aigner, MD · Medias Klinikum Burghausen
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2015-01-31
- Completion
- 2015-05-31
More Related Trials
-
Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases
NCT00264056 ·Status: UNKNOWN ·Phase: NA
-
A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma
NCT00001296 ·Status: COMPLETED ·Phase: PHASE3
-
Isolated Limb Perfusion of Melphalan for Melanoma and Sarcoma Treatment
NCT01920516 ·Status: UNKNOWN
-
A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma
NCT04162015 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO)
NCT06637345 ·Status: RECRUITING
-
Four Versus Six Cycles of Pemetrexed/Platinum for MPM
NCT02497053 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma
NCT00272558 ·Status: COMPLETED ·Phase: PHASE2
-
Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
NCT00030459 ·Status: UNKNOWN ·Phase: PHASE2
-
Intrapleural Cryotherapy for Malignant Pleural Mesothelioma
NCT02464904 ·Status: TERMINATED ·Phase: NA
-
Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel
NCT01666418 ·Status: COMPLETED ·Phase: PHASE2
-
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
NCT05278975 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
NCT00003263 ·Status: COMPLETED ·Phase: PHASE1
-
Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
NCT02784171 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
NCT01163552 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic Melanoma
NCT04663126 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients
NCT04287829 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma
NCT04166734 ·Status: TERMINATED ·Phase: PHASE1
-
Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma
NCT00314106 ·Status: COMPLETED ·Phase: PHASE2
-
Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients
NCT01003626 ·Status: WITHDRAWN ·Phase: NA
-
Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients
NCT02716272 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma
NCT00062933 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity
NCT00001577 ·Status: COMPLETED ·Phase: PHASE1
-
Postoperative Adjuvant Treatment of Completely Resected Mucosal Melanoma Phase II Study
NCT04462965 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma
NCT03710876 ·Status: COMPLETED ·Phase: PHASE3
-
Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node
NCT06754904 ·Status: RECRUITING ·Phase: NA